Soma Analytics UG

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Soma Analytics UG - overview

Established

2011

Location

London, -, UK

Primary Industry

Software

About

Soma Analytics UG develops and reviews nootropic and sleep supplements that enhance cognitive performance and mental health. They provide tailored solutions for individuals seeking improved mental clarity and relaxation. Soma Analytics UG specializes in creating cognitive enhancement products and was founded in 2011 in London, UK. The company was acquired by Prenetics Limited in January 2019, although financial terms were not disclosed.


The founder's prior company history is not available. Soma Analytics specializes in the development and review of nootropic and sleep supplements, aimed at enhancing mental health and cognitive performance. Their product range includes nootropic supplements targeting cognitive functions such as focus and memory, as well as adaptogenic drinks that promote overall mental clarity. They conduct thorough reviews based on real-world testing, helping customers choose effective products tailored to their needs, with a primary focus on individuals seeking cognitive improvement and better sleep.


Their offerings are marketed across North America, Europe, and Asia, catering to a global audience. Revenue for Soma Analytics is generated mainly through direct-to-consumer sales via their website, allowing customers to purchase individual products or subscribe for curated supplement stacks. Pricing varies based on product formulation and benefits, particularly for flagship nootropic supplements and adaptogenic drinks. The company may also engage in partnerships with health retailers to increase distribution and accessibility for their products.


Soma Analytics intends to utilize recent funding for product development, including new nootropic supplements and adaptogenic drinks, set to launch in the coming year. The company is also exploring expansion into additional markets, specifically targeting regions in Asia and North America by 2022. The acquisition by Prenetics Limited in January 2019 is expected to support these growth initiatives, enhancing their distribution capabilities.


Current Investors

Prenetics Global Limited

Primary Industry

Software

Sub Industries

Mental Health Services, Analytics & Performance Software

Website

www.soma-analytics.com

Verticals

Mobile Apps

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.